These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 25027297)
21. Nutritional management of patients with diabetic peripheral neuropathy with L-methylfolate-methylcobalamin-pyridoxal-5-phosphate: results of a real-world patient experience trial. Trippe BS; Barrentine LW; Curole MV; Tipa E Curr Med Res Opin; 2016; 32(2):219-27. PubMed ID: 26439233 [TBL] [Abstract][Full Text] [Related]
23. In vivo effect of methylcobalamin on the peripheral nerve structure in streptozotocin diabetic rats. Yagihashi S; Tokui A; Kashiwamura H; Takagi S; Imamura K Horm Metab Res; 1982 Jan; 14(1):10-3. PubMed ID: 6460676 [TBL] [Abstract][Full Text] [Related]
24. Improvement of cutaneous sensitivity in diabetic peripheral neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5'-phosphate. Walker MJ; Morris LM; Cheng D Rev Neurol Dis; 2010; 7(4):132-9. PubMed ID: 21206429 [TBL] [Abstract][Full Text] [Related]
25. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality. Akahori H; Takamura T; Hayakawa T; Ando H; Yamashita H; Kobayashi K Diabetes Res Clin Pract; 2004 Jun; 64(3):153-9. PubMed ID: 15126001 [TBL] [Abstract][Full Text] [Related]
26. Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers. Toyota T; Hirata Y; Ikeda Y; Matsuoka K; Sakuma A; Mizushima Y Prostaglandins; 1993 Nov; 46(5):453-68. PubMed ID: 8278621 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the Effects of Prophylactic and Therapeutic Administrations on Peripheral Neuropathy in Streptozotocin-Diabetic Rats with Gliclazide or Methylcobalamin. Yao H; Feng J; Zheng Q; Wei Y; Yang G; Feng W Exp Clin Endocrinol Diabetes; 2020 Oct; 128(10):635-643. PubMed ID: 30453342 [TBL] [Abstract][Full Text] [Related]
28. [Electrophysiological changes in diabetic peripheral neuropathy patients of different Chinese medicine syndrome types intervened by naoxintong and mecobalamin]. Huang PJ; Mao XH; Wang YP Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Aug; 31(8):1051-6. PubMed ID: 21910333 [TBL] [Abstract][Full Text] [Related]
29. [Therapeutic effects of prostaglandin E1 in diabetic patients]. Taveggia G; Selletti L Minerva Cardioangiol; 2003 Jun; 51(3):317-22. PubMed ID: 12867884 [TBL] [Abstract][Full Text] [Related]
30. Fasudil combined with methylcobalamin or lipoic acid can improve the nerve conduction velocity in patients with diabetic peripheral neuropathy: A meta-analysis. Jiang DQ; Xu LC; Jiang LL; Li MX; Wang Y Medicine (Baltimore); 2018 Jul; 97(27):e11390. PubMed ID: 29979431 [TBL] [Abstract][Full Text] [Related]
31. Treatment of diabetic neuropathy with diphenylhydantoin. Ellenberg M N Y State J Med; 1968 Oct; 68(20):2653-5. PubMed ID: 4300475 [No Abstract] [Full Text] [Related]
32. Management of diabetic small-fiber neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5'-phosphate. Jacobs AM; Cheng D Rev Neurol Dis; 2011; 8(1-2):39-47. PubMed ID: 21769070 [TBL] [Abstract][Full Text] [Related]
33. Immediate improvement of diabetic mononeuropathy after intravenous administration of prostaglandin E1. Shimizu H; Shimomura Y; Inukai T; Takahashi M; Uehara Y; Kobayashi I; Kobayashi S Jpn J Med; 1990; 29(2):222-5. PubMed ID: 2232371 [TBL] [Abstract][Full Text] [Related]
34. Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients. Kuwabara S; Nakazawa R; Azuma N; Suzuki M; Miyajima K; Fukutake T; Hattori T Intern Med; 1999 Jun; 38(6):472-5. PubMed ID: 10411351 [TBL] [Abstract][Full Text] [Related]
35. Peripheral diabetic neuropathy treated with amitriptyline and fluphenazine. Davis JL; Lewis SB; Gerich JE; Kaplan RA; Schultz TA; Wallin JD JAMA; 1977 Nov; 238(21):2291-2. PubMed ID: 199754 [TBL] [Abstract][Full Text] [Related]
36. Peripheral Neuropathy. Barrell K; Smith AG Med Clin North Am; 2019 Mar; 103(2):383-397. PubMed ID: 30704689 [TBL] [Abstract][Full Text] [Related]
37. Systemic lupus erythematosus with ischemic peripheral neuropathy and lupus anticoagulant: response to intravenous prostaglandin E1. Yoshikawa Y; Mizutani H; Shimizu M Cutis; 1996 Dec; 58(6):393-6. PubMed ID: 8970775 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of prostaglandin E1 plus lipoic acid combination therapy versus monotherapy for patients with diabetic peripheral neuropathy. Jiang DQ; Li MX; Ma YJ; Wang Y; Wang Y J Clin Neurosci; 2016 May; 27():8-16. PubMed ID: 26775115 [TBL] [Abstract][Full Text] [Related]
39. Drug therapy of peripheral neuropathy. Dipalma JR Am Fam Physician; 1981 Feb; 23(2):232-3. PubMed ID: 6257099 [No Abstract] [Full Text] [Related]
40. Conservative treatment of peripheral neuropathy and neuropathic pain. Francis DA; Christopher AT; Beasley BD Clin Podiatr Med Surg; 2006 Jul; 23(3):509-30. PubMed ID: 16958385 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]